Cancer Family
Breast Neoplasm
CI-CAN-00000007Explore in graph →
Non-malignant2,895 active trials43 approved drugs310 evidence items
- NCIt
- C2910
- OncoTree
- BNNOS
- MeSH
- D000069584
- MeSH
- D001943
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000007Explore in graph →
Clinical trials
13,871 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00869674 | GeneSearch™ Breast Lymph Node (BLN) Assay China Registration Study | terminated | Phase 3 | 540 | Johnson & Johnson Medical, ChinaINDUSTRY | 1 | May 30, 2013 | clinicaltrials |
| NCT01200212 | A Randomized Study to Determine the Efficacy of a Taxane and Bevacizumab With or Without Capecitabine as First Line Chemotherapy in Patients With Metastatic Breast Cancer(TABEA) | terminated | Phase 3 | 432 | GBG Forschungs GmbHOTHER | 1 | May 22, 2013 |
| clinicaltrials |
| NCT00005079 | Timing of Menstrual Cycle and Surgery in Treating Premenopausal Women With Stage I, Stage II, or Stage III Breast Cancer | completed | Phase 3 | — | Jonsson Comprehensive Cancer CenterOTHER | 1 | May 15, 2013 | clinicaltrials |
| NCT01433562 | Efficacy and Safety of DLBS1425 as Neoadjuvant in Stage II or III Breast Cancer Patients | completed | Phase 2 / Phase 3 | 40 | Dexa Medica GroupINDUSTRY | 1 | May 13, 2013 | clinicaltrials |
| NCT00083304 | Whole Brain Radiation Therapy With Oxygen, With or Without RSR13, in Women With Brain Metastases From Breast Cancer(ENRICH) | completed | Phase 3 | 368 | Spectrum Pharmaceuticals, IncINDUSTRY | 15 | May 10, 2013 | clinicaltrials |
| NCT00847444 | Docetaxel Based Anthracycline Free Adjuvant Treatment Evaluation, as Well as Life Style Intervention(SUCCESS-C) | unknown | Phase 3 | 3,547 | Philip HeppOTHER | 1 | Apr 19, 2013 | clinicaltrials |
| NCT00002528 | Surgery With or Without Lymph Node Removal in Treating Older Women With Stage I or Stage IIA Breast Cancer(10-93) | completed | Phase 3 | 473 | ETOP IBCSG Partners FoundationNETWORK | 9 | Apr 4, 2013 | clinicaltrials |
| NCT00002529 | Hormone Therapy and Chemotherapy in Treating Perimenopausal or Postmenopausal Women With Node-Positive Breast Cancer(12-93) | completed | Phase 3 | 452 | ETOP IBCSG Partners FoundationNETWORK | 7 | Apr 4, 2013 | clinicaltrials |
| NCT00002784 | High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Combination Chemotherapy in Treating Women With High-Risk Breast Cancer(15-95) | completed | Phase 3 | 344 | ETOP IBCSG Partners FoundationNETWORK | 2 | Apr 4, 2013 | clinicaltrials |
| NCT00003638 | Vaccine Therapy in Treating Women With Metastatic Breast Cancer | completed | Phase 3 | 950 | Oncothyreon Canada Inc.INDUSTRY | 1 | Mar 26, 2013 | clinicaltrials |
| NCT01134523 | Regimens Comparison for Breast Cancers of Positive Lymph Nodes | unknown | Phase 3 | 1,000 | Chinese Academy of Medical SciencesOTHER | 1 | Mar 15, 2013 | clinicaltrials |
| NCT00122356 | Bisphosphonate and Anastrozole Trial - Bone Maintenance Algorithm Assessment(BATMAN) | completed | Phase 3 | 303 | Barwon HealthOTHER_GOV | 1 | Mar 13, 2013 | clinicaltrials |
| NCT00326820 | Ibandronate or Zoledronate in Treating Patients With Newly Diagnosed Bone Metastases From Breast Cancer | unknown | Phase 3 | 1,404 | Wales Cancer Trials UnitOTHER | 1 | Mar 13, 2013 | clinicaltrials |
| NCT01803139 | Long Term Results of the Canadian Breast IMRT Study(IMRT-FU) | unknown | Phase 3 | 358 | Sunnybrook Health Sciences CentreOTHER | 1 | Mar 4, 2013 | clinicaltrials |
| NCT00440622 | Study of Gemcitabine and Herceptin Versus Xeloda and Herceptin in HER-2 (+) Metastatic Breast Cancer Patients | terminated | Phase 3 | 90 | Hellenic Oncology Research GroupOTHER | 1 | Feb 13, 2013 | clinicaltrials |
| NCT00008203 | Comparison of Biological Therapies Following Combination Chemotherapy and Bone Marrow or Peripheral Stem Cell Transplantation in Women With Stage II or Stage III Breast Cancer | completed | Phase 3 | — | Herbert Irving Comprehensive Cancer CenterOTHER | 1 | Feb 4, 2013 | clinicaltrials |
| NCT00291759 | ABCSG 8 - Adjuvant Treatment in Patients With Hormone Receptor-positive Breast Cancer With Good to Moderate Differentiation. | completed | Phase 3 | 3,858 | AstraZenecaINDUSTRY | 1 | Jan 30, 2013 | clinicaltrials |
| NCT00002772 | S9623, Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer | terminated | Phase 3 | 602 | SWOG Cancer Research NetworkNETWORK | 1 | Jan 24, 2013 | clinicaltrials |
| NCT00005983 | S9927 Radiation Therapy After Surgery, Chemotherapy, and/or Hormone Therapy in Stage II Breast Cancer | terminated | Phase 3 | 98 | SWOG Cancer Research NetworkNETWORK | 1 | Jan 24, 2013 | clinicaltrials |
| NCT00016406 | S0012 Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Filgrastim in Treating Women With Inflammatory or Locally Advanced Breast Cancer | completed | Phase 3 | 399 | SWOG Cancer Research NetworkNETWORK | 1 | Jan 24, 2013 | clinicaltrials |
| NCT00929591 | SWOG-8814 Tamoxifen With or Without Combination Chemotherapy in Postmenopausal Women Who Have Undergone Surgery for Breast Cancer | completed | Phase 3 | 1,558 | SWOG Cancer Research NetworkNETWORK | 0 | Jan 24, 2013 | clinicaltrials |
| NCT00016276 | Combination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treating Women With Stage III or Stage IV Breast Cancer | terminated | Phase 3 | 396 | National Cancer Institute (NCI)NIH | 1 | Jan 16, 2013 | clinicaltrials |
| NCT01611051 | A Study Comparing Pegylated rhG-CSF and rhG-CSF as Support to Breast Cancer Patients Receiving Chemotherapy | completed | Phase 3 | 330 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | Jan 8, 2013 | clinicaltrials |
| NCT00262899 | Genetic Counseling or Usual Care in Helping Women With Newly Diagnosed Ductal Carcinoma In Situ or Stage I, Stage II, or Stage IIIA Breast Cancer Make Treatment Decisions | completed | Phase 3 | 331 | Georgetown UniversityOTHER | 1 | Jan 7, 2013 | clinicaltrials |
| NCT01752686 | A Phase III Trial of Carboplatin as Adjuvant Chemotherapy in Triple Negative Breast Cancer | unknown | Phase 3 | 587 | Severance HospitalOTHER | 0 | Dec 25, 2012 | clinicaltrials |
| NCT00089479 | A Study of Xeloda (Capecitabine) in Women With High-Risk Breast Cancer | completed | Phase 3 | 2,611 | Hoffmann-La RocheINDUSTRY | 1 | Dec 21, 2012 | clinicaltrials |
| NCT00230711 | Physical Activity Promotion in Cancer Follow-Up Care | completed | Phase 3 | 300 | The Miriam HospitalOTHER | 1 | Nov 30, 2012 | clinicaltrials |
| NCT00324714 | Risedronate in Improving Bone Mineral Density and Bone Health in Postmenopausal Women With Ductal Carcinoma In Situ Enrolled in Clinical Trial CRUK-IBIS-II-DCIS | withdrawn | Phase 3 | 0 | ETOP IBCSG Partners FoundationNETWORK | 1 | Nov 29, 2012 | clinicaltrials |
| NCT00002920 | S9630, Medroxyprogesterone in Treating Women With Breast Cancer | completed | Phase 3 | 313 | SWOG Cancer Research NetworkNETWORK | 1 | Oct 31, 2012 | clinicaltrials |
| NCT00201890 | Trial of Decongestive Lymphatic Therapy for Lymphedema in Women With Breast Cancer "DELTA STUDY" | completed | Phase 3 | 103 | Ontario Clinical Oncology Group (OCOG)OTHER | 1 | Oct 10, 2012 | clinicaltrials |
| NCT00917748 | Study With Modafinil in Patients Treated With Docetaxel-Based Chemotherapy for Metastatic Breast or Prostate Cancer (MOTIF) | completed | Phase 3 | 84 | SanofiINDUSTRY | 1 | Sep 26, 2012 | clinicaltrials |
| NCT00147108 | MR Guided Focused Ultrasound Surgery in the Treatment of Breast Fibroadenomas | terminated | Phase 3 | 102 | InSightecINDUSTRY | 2 | Sep 17, 2012 | clinicaltrials |
| NCT00373256 | A Study Of SU011248 Plus Paclitaxel Versus Bevacizumab Plus Paclitaxel In Patients With Advanced Breast Cancer | completed | Phase 3 | 488 | PfizerINDUSTRY | 4 | Sep 10, 2012 | clinicaltrials |
| NCT00605267 | Arimidex/Tamoxifen Neo Adjuvant Study in Premenopausal Patients With Breast Cancer Under Anti Hormonal Treatment | completed | Phase 3 | 197 | AstraZenecaINDUSTRY | 1 | Sep 6, 2012 | clinicaltrials |
| NCT01662128 | Efficacy and Safety Of Xeloda as Sequential Adjuvant Therapy After Chemotherapy in Breast Cancer | unknown | Phase 2 / Phase 3 | 600 | Tianjin Medical UniversityOTHER | 1 | Aug 10, 2012 | clinicaltrials |
| NCT01648608 | Efficacy and Safety of TAC and Exemestane as Neoadjuvant Chemotherapy in the Postmenopausal Women With Breast Cancer | unknown | Phase 2 / Phase 3 | 600 | Tianjin Medical UniversityOTHER | 1 | Aug 3, 2012 | clinicaltrials |
| NCT00256698 | Anastrozole Monotherapy Versus Maximal Oestrogen Blockade With Anastrozole and Fulvestrant Combination Therapy(FACT) | completed | Phase 3 | 514 | AstraZenecaINDUSTRY | 12 | Aug 1, 2012 | clinicaltrials |
| NCT01654367 | Research of Zoledronic Acid and Aromatase Inhibitors as Adjuvant Therapy to Breast Cancer(esozao) | unknown | Phase 2 / Phase 3 | 300 | Tianjin Medical UniversityOTHER | 1 | Jul 31, 2012 | clinicaltrials |
| NCT00008411 | Docetaxel in Treating Patients With Metastatic Breast Cancer | completed | Phase 3 | 90 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 30, 2012 | clinicaltrials |
| NCT00343616 | Cognitive Function in Postmenopausal Women With Breast Cancer Receiving Hormone Therapy on Clinical Trial IBCSG-1-98 | completed | Phase 3 | 135 | ETOP IBCSG Partners FoundationNETWORK | 6 | Jul 27, 2012 | clinicaltrials |
| NCT00369850 | Bone Density and Bone Loss in Postmenopausal Women With Breast Cancer Receiving Treatment in Clinical Trial IBCSG-1-98 | completed | Phase 3 | 458 | ETOP IBCSG Partners FoundationNETWORK | 8 | Jul 27, 2012 | clinicaltrials |
| NCT00899288 | Fingernails in Evaluating Bone Health in Postmenopausal Women With Breast Cancer Undergoing Hormone Therapy on Clinical Trial IBCSG-1-98 | terminated | Phase 3 | 60 | ETOP IBCSG Partners FoundationNETWORK | 0 | Jul 27, 2012 | clinicaltrials |
| NCT01647672 | Efficacy and Safety With Albumin-bound Paclitaxel (Abraxane) in the TAC as Neoadjuvant Chemotherapy in Breast Cancer | unknown | Phase 2 / Phase 3 | 60 | Tianjin Medical UniversityOTHER | 1 | Jul 25, 2012 | clinicaltrials |
| NCT00038402 | Evaluation of the Addition of Herceptin to Standard Chemotherapy in the Neoadjuvant Setting for Operable Breast Cancer | completed | Phase 3 | 74 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 20, 2012 | clinicaltrials |
| NCT00010153 | ICI 182780 in Treating Women With Stage I or Stage II Primary Breast Cancer | terminated | Phase 3 | — | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 1 | Jul 19, 2012 | clinicaltrials |
| NCT00393939 | Study Of Sunitinib In Combination With Docetaxel Vs Docetaxel In Patients With Advanced Breast Cancer(SUN 1064) | completed | Phase 3 | 594 | PfizerINDUSTRY | 27 | Jul 19, 2012 | clinicaltrials |
| NCT00028704 | Breast-Conserving Therapy Compared With Mastectomy Followed By Radiation Therapy in Treating Women With Locally Advanced Breast Cancer Previously Treated With Chemotherapy | terminated | Phase 3 | 26 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 7 | Jul 18, 2012 | clinicaltrials |
| NCT00049660 | Capecitabine Compared With Vinorelbine in Treating Women With Metastatic Breast Cancer | terminated | Phase 2 / Phase 3 | 47 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 5 | Jul 18, 2012 | clinicaltrials |
| NCT01501669 | Irinotecan/Capecitabine Versus Capecitabine in Patients Treated With A/T for HER2 Negative Metastatic Breast Cancer(PROCEED) | unknown | Phase 3 | 222 | National Cancer Center, KoreaOTHER_GOV | 1 | Jul 18, 2012 | clinicaltrials |
| NCT00002777 | Exemestane Compared With Tamoxifen in Treating Women With Locally Recurrent or Metastatic Breast Cancer | completed | Phase 3 | 342 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 12 | Jul 2, 2012 | clinicaltrials |
Data updated 23 days agoSource updated May 30, 2013source: clinicaltrials